Md Michael Frank

Indiana Univ-Purdue Univ At Indianapolis

Attributed

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

NIH$0 · 3

By mechanism

M01$0 · 3

Top collaborators

No co-investigators on record.

Most similar at Indiana Univ-Purdue Univ At Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
George R Seage · Abt Associates, Inc.$172,422,660
Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
Jeffrey P Krischer · University Of South Florida$155,493,283
Charles A Coltman · Southwest Oncology Group$154,811,913

Research focus

Human SubjectHuman Therapy EvaluationAntiaids AgentClinical ResearchCombination ChemotherapyAids TherapyHiv InfectionsZidovudineDrug Screening /EvaluationLamivudineProtease InhibitorReverse Transcriptase InhibitorsStavudineHydroxyureaIndinavir2'3'Dideoxyinosine

Grant awards (21)

AMPRENAVIR, ABACAVIR, EFAVIRENZ, ADEFOVIR DIPIVOXIL VS AMPRENAVIR ALO$0

M01 · FY2002 · RR

SALVAGE ANTIRETROVIRAL THERAPIES FOR HIV INFECTED INDIVIDUALS$0

M01 · FY2002 · RR

SAFETY &EFFICACY OF HYDROXYUREA IN SUBJECTS ON POTENT ANTIRETROVIRAL$0

M01 · FY2002 · RR

AMPRENAVIR, ABACAVIR, EFAVIRENZ, ADEFOVIR DIPIVOXIL VS AMPRENAVIR ALO$0

M01 · FY2001 · RR

SALVAGE ANTIRETROVIRAL THERAPIES FOR HIV INFECTED INDIVIDUALS$0

M01 · FY2001 · RR

SAFETY &EFFICACY OF HYDROXYUREA IN SUBJECTS ON POTENT ANTIRETROVIRAL$0

M01 · FY2001 · RR

SALVAGE ANTIRETROVIRAL THERAPIES FOR HIV INFECTED INDIVIDUALS$0